logo

Exhibiting at VIV Asia 2025

3-4910
Bangkok
12 Mar - 14 Mar, 2025

Product Offerings

Products:

Phenbrozole Solution: Fenbendazole-based anthelmintic solution for livestock

SI Ivermectin Premix: Ivermectin-based premix for parasite control in animals

Hytril Solution: Veterinary solution for specific therapeutic applications

FTD Injection: Injectable veterinary medicine for various treatments

Dexferron Injection: Iron and vitamin B12 injection to prevent anemia in piglets

SB Shinil Co., Ltd. is a leading South Korean veterinary pharmaceutical manufacturer based in Yesan-gun, Chungcheongnam-do, Republic of Korea. The company specializes in developing, manufacturing, and distributing a wide range of veterinary medicines aimed at improving animal health and productivity across the livestock industry. With a strong presence in domestic markets and a growing footprint in Asia, SB Shinil is committed to producing safe, effective, and regulation-compliant veterinary pharmaceuticals.

Core Business and Offerings

SB Shinil Co., Ltd. manufactures a broad spectrum of veterinary products covering parasiticides, injectables, oral solutions, and premixes designed for poultry, swine, and ruminant applications. Its flagship products include:

  • Phenbrozole Solution:

    • A fenbendazole-based broad-spectrum anthelmintic solution used to treat and prevent internal parasite infestations in livestock.
    • Effective against gastrointestinal nematodes and lungworms.
  • SI Ivermectin Premix:

    • A medicated feed additive containing ivermectin, used for controlling both internal and external parasites in pigs and ruminants.
    • Widely used in integrated pig farming systems for parasite control and performance enhancement.
  • Hytril Solution:

    • A specialized veterinary solution used for respiratory or systemic conditions, tailored for targeted therapy (specific formulation details not disclosed publicly).
  • FTD Injection:

    • A multi-purpose injectable formulation used in supportive treatment regimens in livestock.
  • Dexferron Injection:

    • A combination of iron and vitamin B12, formulated to prevent and treat iron-deficiency anemia in piglets and newborn animals.

These products are manufactured under strict quality control systems and are widely used in commercial farms, veterinary clinics, and animal health programs.

Specialization and Core USP

SB Shinil’s primary value lies in its ability to:

  • Formulate targeted veterinary solutions that are adapted to the production systems of East and Southeast Asia.
  • Produce high-efficacy parasiticides with excellent safety profiles.
  • Develop injectable therapies that improve survival and productivity of piglets and young livestock during the most vulnerable growth stages.
  • Maintain a flexible product line that includes both bulk and small-volume formulations for varying customer segments.

The company is especially known for its focus on piglet health products, including treatments for anemia and parasitic control, which are critical in intensive swine production.

Financial Performance

While SB Shinil is a privately held company and does not publish detailed financial reports, trade estimates and industry sources suggest:

  • Annual revenue estimated between USD $5–8 million, driven primarily by domestic sales and targeted exports.
  • A consistent customer base among Korean integrators and livestock cooperatives.
  • Active investment in product development and GMP-certified manufacturing infrastructure, enhancing the company’s capabilities and compliance profile.

The company is regarded as a mid-tier veterinary pharmaceutical player in South Korea, with scalable infrastructure and a strong regional reputation.

Shipment Records

Based on public export records and trade insights:

  • SB Shinil supplies products to regional partners in Vietnam, Philippines, Indonesia, and Bangladesh.
  • Frequent exports include fenbendazole and ivermectin-based products used in intensive livestock and aquaculture systems.
  • Products are typically shipped in carton boxes, HDPE bottles, and glass ampoules, with appropriate storage and regulatory documentation.
  • Export volumes remain steady at dozens of shipments annually, especially of parasite control solutions and injectables.

Target Market

SB Shinil serves a well-defined customer base:

  • Commercial pig and poultry producers
  • Veterinary hospitals and private practices
  • Animal health distributors in Asia
  • Feed millers and integrators needing premix formulations
  • Government and NGO-led veterinary health campaigns

Its products cater to markets that prioritize cost-effective, proven, and locally adaptable veterinary therapeutics.

Capabilities

  • GMP-compliant manufacturing facilities
  • Sterile injectable and solution production lines
  • R&D division focused on formulation refinement and clinical efficacy
  • Veterinary technical services team for product use guidance and after-sales support
  • Capacity to handle contract manufacturing and private label production for regional distributors

SB Shinil is structured to support B2B partnerships, particularly in Asia-Pacific markets that demand local registration, technical compliance, and consistent supply.

Certifications and Compliance

  • Compliant with Korean GMP (KGMP) for veterinary pharmaceuticals
  • Registered with Korea Animal and Plant Quarantine Agency (APQA)
  • Products are formulated in adherence to pharmacopoeial standards
  • Export documents, Certificates of Analysis (COA), and MSDS provided as standard
  • Committed to safety, efficacy, and environmental stewardship

Regulatory credibility is a key strength, facilitating swift market access across regulated and semi-regulated regions.

Customer Testimonials

“SB Shinil's ivermectin premix has become a regular component of our feed mill formulation. Its parasite control efficacy is reliable, with excellent animal tolerance.”
– Animal Nutritionist, Swine Integrator, Vietnam

“Dexferron Injection has helped reduce piglet mortality rates due to anemia. Easy to administer and well-accepted by our field staff.”
– Livestock Technician, South Korea

Major Achievements

  • Introduced specialized anthelmintic and injectable piglet care line with high adoption in Korean pig farms.
  • Expanded international presence with successful product registrations in Southeast Asia.
  • Invested in GMP-level infrastructure, boosting its capacity to support both domestic and contract manufacturing clients.
  • Recognized as a trusted technical supplier by major Korean feed mills and livestock cooperatives.
  • Maintains an impressive customer retention rate due to consistent product quality and strong technical support.

SB Shinil Co., Ltd. continues to build on its legacy as a reliable, science-driven partner in veterinary pharmaceuticals, helping animal producers achieve healthier herds and higher productivity through effective, compliant, and accessible veterinary solutions.